HARROW HEALTH, INC. (IMMY) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues
Three Suppliers	26.8				16.8
Four Product Concentration Risk	16.1				7.5
Single Customer	9.0
Two Product Concentration Risk		9.4	7.6	7.8		7.1	6.5	6.5

EBIT
Pharmaceutical Drug Development							-8.7
Corporate							-13.7

Mix
Three Suppliers	80.0%				72.0%
Four Product Concentration Risk	48.0%				32.0%
Single Customer	27.0%
Two Product Concentration Risk		36.0%	37.4%	34.0%		32.0%	32.4%	35.0%

Growth
Three Suppliers	59.5%
Four Product Concentration Risk	115.3%
Two Product Concentration Risk		32.8%	16.1%	18.5%